×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MBOT – microbot medical inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MBOT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:18 am
mbot
Microbot Medical (NASDAQ:MBOT) was upgraded by analysts at Roth Capital to a "strong-buy" rating. They now have a $5.50 price target on the stock.
Low
Report
Microbot Medical (NASDAQ:MBOT) was upgraded by analysts at Roth Capital to a "strong-buy" rating. They now have a $5.50 price target on the stock.
12/3
05:11 am
mbot
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
High
Report
Microbot Medical (NASDAQ:MBOT) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
11/28
07:02 am
mbot
Microbot Medical (NASDAQ:MBOT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Microbot Medical (NASDAQ:MBOT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/26
08:30 am
mbot
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
High
Report
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
11/5
08:30 am
mbot
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
Medium
Report
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
10/25
12:09 pm
mbot
Microbot Medical (NASDAQ:MBOT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Microbot Medical (NASDAQ:MBOT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
10/16
08:30 am
mbot
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
Medium
Report
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
10/15
08:12 am
mbot
Microbot Medical (NASDAQ:MBOT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Microbot Medical (NASDAQ:MBOT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/26
08:30 am
mbot
Form 8-K Microbot Medical Inc. For: Nov 26
High
Report
Form 8-K Microbot Medical Inc. For: Nov 26
11/19
05:16 pm
mbot
Form 424B3 Microbot Medical Inc.
Medium
Report
Form 424B3 Microbot Medical Inc.
11/19
05:16 pm
mbot
Form 424B3 Microbot Medical Inc.
Medium
Report
Form 424B3 Microbot Medical Inc.
11/12
04:18 pm
mbot
Form 10-Q Microbot Medical Inc. For: Sep 30
Medium
Report
Form 10-Q Microbot Medical Inc. For: Sep 30
11/7
05:27 pm
mbot
Form SCHEDULE 13G/A Microbot Medical Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Low
Report
Form SCHEDULE 13G/A Microbot Medical Inc. Filed by: INTRACOASTAL CAPITAL, LLC
11/5
08:31 am
mbot
Form 8-K Microbot Medical Inc. For: Nov 05
Medium
Report
Form 8-K Microbot Medical Inc. For: Nov 05
10/31
11:03 am
mbot
Form SCHEDULE 13G/A Microbot Medical Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Microbot Medical Inc. Filed by: VANGUARD GROUP INC
10/28
05:30 pm
mbot
Form S-3/A Microbot Medical Inc.
Low
Report
Form S-3/A Microbot Medical Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/23
Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures
74.9%
9/5 Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference 41.2%
12/24 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, up previously from $10.00. 23.1%
2/21 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 16.9%
1/2 Form SC 13D/A Microbot Medical Inc. Filed by: Gadot Harel 12.5%
12/26 Form 4 Microbot Medical Inc. For: Dec 23 Filed by: Gadot Harel 11.3%
3/17 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.4%
9/11 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock. 5.6%
10/30 Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform 5.1%
7/22 Microbot Medical Inc (NASDAQ: MBOT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.0%
9/5 Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference 41.2%
12/24 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, up previously from $10.00. 23.1%
2/21 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 16.9%
1/2 Form SC 13D/A Microbot Medical Inc. Filed by: Gadot Harel 12.5%
12/26 Form 4 Microbot Medical Inc. For: Dec 23 Filed by: Gadot Harel 11.3%
3/17 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.4%
9/11 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock. 5.6%
10/30 Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform 5.1%
7/22 Microbot Medical Inc (NASDAQ: MBOT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.0%
TOP News Decliners
12/27
Form 424B5 Microbot Medical Inc.
-24.0%
12/26 Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -21.5%
12/30 Microbot Medical Inc. Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -16.9%
9/10 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%
1/13 Form 8-K Microbot Medical Inc. For: Jan 13 -14.6%
4/1 Microbot Medical Appoints Aileen Stockburger to the Board of Directors -11.5%
12/11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers [Seeking Alpha] -10.9%
12/31 Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock -8.0%
10/30 Form 8-K Microbot Medical Inc. For: Oct 30 -7.5%
5/1 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $26.00. -7.0%
12/26 Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -21.5%
12/30 Microbot Medical Inc. Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -16.9%
9/10 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%
1/13 Form 8-K Microbot Medical Inc. For: Jan 13 -14.6%
4/1 Microbot Medical Appoints Aileen Stockburger to the Board of Directors -11.5%
12/11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers [Seeking Alpha] -10.9%
12/31 Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock -8.0%
10/30 Form 8-K Microbot Medical Inc. For: Oct 30 -7.5%
5/1 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $26.00. -7.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: